June 2026
The global small molecule innovator CDMO market size is valued at USD 59.96 billion in 2026 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
September 2026
The global small molecule API market size was valued at USD 217 billion in 2026 and is projected to surpass around USD 347.45 billion by 2035 with a CAGR of 5.38%.
September 2026
The global small molecule immunomodulators market size is projected to hit around USD 339.54 billion by 2035 from USD 198.69 billion by 2026, at a CAGR of 6.14%.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 208.51 billion in 2026, with a CAGR of 5.68%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
December 2025
The global outsourced small-molecule API manufacturing market grows as pharma companies partner with CDMOs for cost-efficient, scalable, and compliant API production.t
September 2026
The small caliber ammunition market size is evaluated at USD 10.81 billion in 2026 and is expected to hit around USD 15.08 billion by 2035 with a CAGR of 3.77%.
September 2026
The global veterinary CRO and CDMO market size was valued at USD 8.38 billion in 2026 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 20.45 billion in 2026 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
September 2026
The small commercial vehicle market size was valued at USD 597.36 billion in 2026 and is projected to hit around USD 916.76 billion by 2034, expanding at a CAGR of 5.5%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 49.06 billion in 2026, growing at a CAGR of 7.59%.
September 2026
The global small SUVs market size is estimated at USD 560.63 billion in 2026 and is expected to hit around USD 590 billion by 2034 with a CAGR of 0.64%.
September 2026
The global small UAV market size is valued at USD 9.49 billion in 2026 and is projected to hit around USD 40.15 billion by 2034 with a CAGR of 17.54%
September 2026
The global biologics CDMO market size was valued at USD 25.08 billion in 2026 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
September 2026
The global small-scale LNG market size was evaluated at USD 78.18 billion in 2026 and is expected to attain around USD 250.63 billion by 2035, with a CAGR of 13.85%.
September 2026
The small nuclear reactor market reached USD 8.16 billion in 2026, featuring leading small nuclear reactor market companies such as Deutsche Post DHL Group, United Parcel Service (UPS), FedEx Corporation, Kuehne + Nagel, DB Schenker.
September 2026
The chemical drug CDMO market size was USD 14.32 billion in 2026, with leading chemical drug CDMO market players including Almac Group, BASF SE, Boehringer Ingelheim, Cipla Limited.
September 2026
The chemical API CDMO market size was USD 18.36 billion in 2026, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
September 2026
The global small hydropower market size was evaluated at USD 2.39 billion in 2026 and is projected to surpass around USD 3.07 billion by 2035 with a CAGR of 2.80%.
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
August 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
August 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2026
The global small-scale bioreactors market size is calculated at USD 2.92 billion in 2025 and is projected to hit around USD 10.56 billion by 2035 with a CAGR of 13.72%
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 5.19 billion in 2026, with a CAGR of 9.59%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com